Impact of suture annuloplasty repair for moderate functional tricuspid regurgitation in rheumatic patients undergoing mitral valve replacement (Early outcome)
Background: In this study, we examine the outcomes of tricuspid valve repair against non-repair to see if there is a near-term progression of non-corrected moderate functional TR in patients who had mitral valve replacement for rheumatic mitral disease and if RV size and function were affected. Objectives: To evaluate the effect of the De Vega annuloplasty for repair of moderate functional TV regurge during the left heart valve surgery in early post-operative period. Patients and methods:A prospective randomized controlled trial will contain (forty patients aged from 25 to 55 years of both sexes )they will be divided into two groups of patients: Group A: Twenty patients with moderate functional tricuspid regurgitation who received tricuspid valve annuloplasty (TVA) in the form of De vega repair along with mitral valve replacement. Group B: Twenty patients with moderate functional tricuspid regurgitation who received mitral valve replacement without tricuspid valve annuloplasty (TVA). Results: TR and right ventricle diameter were found to be significantly reduced in Group A. In group B, (6) individuals (30%) had developed grade IV/IV TR after 6 months, while 65% of patients developed competent tricuspid valve after 6 months in group A .Furthermore, in group B, TABSE (tricuspid annular systemic excursion) had dropped significantly to 1.7±0.2 cm. Conclusion: In the early postoperative period, tricuspid suture annuloplasty combined with MVR can prevent the advancement of tricuspid regurgitation, right ventricular dilatation, and systolic dysfunction..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
---|---|
Enthalten in: |
SVU - International Journal of Medical Sciences - 5(2022), 2, Seite 362-373 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hazem Gamal Bakr* [VerfasserIn] |
---|
Links: |
dx.doi.org [kostenfrei] |
---|
Themen: |
Medicine |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
DOAJ041348087 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ041348087 | ||
003 | DE-627 | ||
005 | 20230308045533.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ041348087 | ||
035 | |a (DE-599)DOAJcf45f0efcffa4fafba6368de155c7064 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Hazem Gamal Bakr* |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of suture annuloplasty repair for moderate functional tricuspid regurgitation in rheumatic patients undergoing mitral valve replacement (Early outcome) |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: In this study, we examine the outcomes of tricuspid valve repair against non-repair to see if there is a near-term progression of non-corrected moderate functional TR in patients who had mitral valve replacement for rheumatic mitral disease and if RV size and function were affected. Objectives: To evaluate the effect of the De Vega annuloplasty for repair of moderate functional TV regurge during the left heart valve surgery in early post-operative period. Patients and methods:A prospective randomized controlled trial will contain (forty patients aged from 25 to 55 years of both sexes )they will be divided into two groups of patients: Group A: Twenty patients with moderate functional tricuspid regurgitation who received tricuspid valve annuloplasty (TVA) in the form of De vega repair along with mitral valve replacement. Group B: Twenty patients with moderate functional tricuspid regurgitation who received mitral valve replacement without tricuspid valve annuloplasty (TVA). Results: TR and right ventricle diameter were found to be significantly reduced in Group A. In group B, (6) individuals (30%) had developed grade IV/IV TR after 6 months, while 65% of patients developed competent tricuspid valve after 6 months in group A .Furthermore, in group B, TABSE (tricuspid annular systemic excursion) had dropped significantly to 1.7±0.2 cm. Conclusion: In the early postoperative period, tricuspid suture annuloplasty combined with MVR can prevent the advancement of tricuspid regurgitation, right ventricular dilatation, and systolic dysfunction. | ||
650 | 4 | |a tricuspid valve surgery; repair; suture annuloplasty; and mitral valve replacement | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Emmanuel Louka Aziz |e verfasserin |4 aut | |
700 | 0 | |a Ahmed Talaat Ahmed Ramadan |e verfasserin |4 aut | |
700 | 0 | |a Ashraf Mohamed Abd El-Aziz Hassan |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t SVU - International Journal of Medical Sciences |d South Valley University, Faculty of Medicine, 2021 |g 5(2022), 2, Seite 362-373 |w (DE-627)DOAJ078613108 |x 26363402 |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2022 |g number:2 |g pages:362-373 |
856 | 4 | 0 | |u https://dx.doi.org/10.21608/svuijm.2022.124028.1284 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/cf45f0efcffa4fafba6368de155c7064 |z kostenfrei |
856 | 4 | 0 | |u https://svuijm.journals.ekb.eg/article_224867.html |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2735-427X |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2636-3402 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 5 |j 2022 |e 2 |h 362-373 |